Lung overinflation without positive end-expiratory pressure promotes bacteremia after experimental Klebsiella pneumoniae inoculation

Intensive Care Medicine

Volumn 24, Issue 2, 1998, Pages 172-177

  Verbrugge, S J C ^a   Sorm V ^a   Van 'T Veen, A ^a   Mouton, J W ^a   Gommers, D ^a   Lachmann, B ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Animal; Bacteremia; Blood gases; K. pneumoniae; Mechanical ventilation; Rat

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL BLOOD; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BLOOD CULTURE; BLOOD GAS; CONTROLLED STUDY; KLEBSIELLA PNEUMONIAE; LUNG INFLATION; MALE; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; RAT;

ANIMALS; BACTEREMIA; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; POSITIVE-PRESSURE RESPIRATION; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATION, ARTIFICIAL;

EID: 0031942873     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050541     Document Type: Article

References (24)

1. Montgomery AB, Stager MA, Carrico CJ, Hudson LD (1985) Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 132: 485-489
2. Swank GM, Deitch EA (1996) Role of the gut in multiple organ failure: Bacterial translocation and permeability changes. World J Surg 20: 411-417
3. Schlag G. Redl H (1996) Mediators of injury and inflammation. World J Surg 20: 406-410
4. Tremblay L, Valenza F, Riheiro SP. Jingfang L, Slutsky AS (1997) Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 99: 944-952
5. Von Bethmann AN, Brasch F, Müller K, Wendel A, Uhlig S (1996) Prolonged hyperventilation is required for release of tumor necrosis factor a but not IL-6. Appl Cardiopulm Pathophysiol 6: 171-177
6. Van 't Veen A, Mouton JW, Gommers D, Lachmann B (1996) Pulmonary surfactant as vehicle for intratracheally instilled tobramycin in mice infected with Klebsiella pneumoniae. Br J Pharmacol 119: 1145-1148
7. Roosendaal R, Bakker IAJM, Van den Berghe-van Raffe M, Michel MF (1986) Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats. Antimicrob Agents Chemother 30: 413-408
8. Webb HH, Tierney DF (1974) Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures, Protection by positive end-expiratory pressure. Am Rev Respir Dis 110: 556-565
9. Dreyfuss D, Basset G, Soler P, Saumon G (1985) Intermittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats. Am Rev Respir Dis 132: 880-884
10. Dreyfuss D, Soler P, Basset G, Saumon G (1988) Intermittent positive pressure pulmonary edema: respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 137: 1159-1164
11. LaForce FM, Mullane JF, Boehme RF, Kelly WJ, Huber GL (1973) The effect of pulmonary edema on antibacterial defenses of the lung. J Lab Clin Med 82: 634-648
12. Brough-Holub E, Toews GB, van Iwaarden F. Stricter RM, Kunkel SL, Paine III R, Standiford TJ (1997) Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella Pneumonia: Elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect Immun 65: 1139-1146
13. Lachmann B, Eijking EP, So KL, Gommers D (1994) In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function. Intensive Care Med 20: 6-11
14. Van 't Veen, Gommers D, Lachmann B (1997) Rationale for surfactant therapy in pneumonia. In: Vincent JL (ed) Year book of Intensive Care and Emergency Medicine. Springer, Berlin Heidelberg. pp638-653
15. Huber JL, Johanson WG, La Force FM (1977) Experimental models and pulmonary antimicrobial defenses. In: Brian JD, Proctor DF, Reid L (eds) Respiratory defense mechanisms. Dekker. New York, pp 983-1022
16. Gøthgen IH, Berthelsen PG, Rasmussen JP, Jacobsen E (1993) Ventilation in ARDS and asthma: the optimal blood gas values. Scand J Clin Lab Invest Suppl 214: 67-73
17. Seidenfeld JJ, Mullins RC, Fowler SR, Johanson WG (1986) Bacterial infection and acute lung injury in hamsters. Am Rev Respir Dis 134: 22-26
18. Tilson MD, Bunke MC, Walker Smith GJ, Katz J, Cronau L, Barash PG, Baue AE (1977) Quantitative bacteriology and pathology of the lung in experimental Pseudomonas pneumonia treated with positive end-expiratory pressure (PEEP). Surgery 82: 133-140
19. Johanson WG, Higuchi JH, Woods DE, Gomez P, Coalson JJ (1985) Dissemination of Pseudomonas aeruginosa during lung infection in hamsters. Role of oxygen-induced lung injury. Am Rev Respir Dis 132: 358-361
20. Tremblay LN, Slutsky AS (1996) The role of pressure and volume in ventilator induced lung injury. Appl Cardiopulm Pathophysiol 6: 179-190
21. Dreyfuss D, Saumon G (1993) Role of tidal volume, FRC, and end-inspiratory volume in the development of pulmonary edema following mechanical ventilation. Am Rev Respir Dis 148: 1194-1203
22. Taskar V, John J, Evander E, Roberston B, Jonson B (1997) Surfactant dysfunction makes lungs vulnerable to repetitive collapse and reexpansion. Am J respir Crit Care Med 155: 313-320
23. Brigham KL (1982) Mechanisms of lung injury. Clin Chest Med 3: 9-24
24. Tyler DC (1983) Positive end-expiratory pressure: A review. Crit Care Med 11: 300-308